Publication:
Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature

Simple item page
dc.contributor.authorsTahan, V.; Ozseker, F.; Guneylioglu, D.; Baran, A.; Ozaras, R.; Mert, A.; Ucisik, A. C.; Cagatay, T.; Yilmazbayhan, D.; Senturk, H.
dc.date.accessioned2022-03-15T11:09:53Z
dc.date.accessioned2026-01-11T06:57:06Z
dc.date.available2022-03-15T11:09:53Z
dc.date.issued2003
dc.description.abstractAlthough interferon has not been classified in the pathogenesis of sarcoidosis, it may rarely lead to this disease during treatment of chronic hepatitis C. The case of a 36-year-old woman with chronic hepatitis C who developed sarcoidosis within 10 weeks of treatment with recombinant interferon-alpha2a and ribavirin is described and all seven similar cases published in English from 1989 to 2001 are discussed.
dc.identifier.doi10.1023/a:1021759120428
dc.identifier.issn0163-2116
dc.identifier.pubmedPMID: 12645805
dc.identifier.urihttps://hdl.handle.net/11424/248484
dc.language.isoeng
dc.relation.ispartofDigestive Diseases and Sciences
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAdult
dc.subjectFemale
dc.subjectHumans
dc.subjectAntiviral Agents
dc.subjectDrug Therapy, Combination
dc.subjectHepatitis C, Chronic
dc.subjectInterferon alpha-2
dc.subjectInterferon-alpha
dc.subjectRecombinant Proteins
dc.subjectRibavirin
dc.subjectSarcoidosis, Pulmonary
dc.titleSarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage173
oaire.citation.startPage169
oaire.citation.titleDigestive Diseases and Sciences
oaire.citation.volume1

Files

Collections

Araştırma Çıktıları